- Home
- TATT vs RAPT Comparison
TATT vs RAPT Comparison
Compare TATT & RAPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TATT | RAPT |
|---|---|---|
| Founded | 1985 | 2015 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Aerospace | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 505.2M | 498.4M |
| IPO Year | 1987 | 2019 |
Fundamental Metrics
Financial Performance| Metric | TATT | RAPT |
|---|---|---|
| Price | $43.16 | $36.47 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 10 |
| Target Price | $47.25 | ★ $57.00 |
| AVG Volume (30 Days) | 143.9K | ★ 481.3K |
| Earning Date | 11-12-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 75.30 | N/A |
| EPS | ★ 1.33 | N/A |
| Revenue | ★ $172,525,000.00 | N/A |
| Revenue This Year | $20.32 | N/A |
| Revenue Next Year | $17.29 | N/A |
| P/E Ratio | $30.20 | ★ N/A |
| Revenue Growth | ★ 20.72 | N/A |
| 52 Week Low | $22.57 | $5.67 |
| 52 Week High | $45.83 | $42.39 |
Technical Indicators
Market Signals| Indicator | TATT | RAPT |
|---|---|---|
| Relative Strength Index (RSI) | 63.35 | 61.98 |
| Support Level | $38.01 | $31.70 |
| Resistance Level | $40.52 | $38.45 |
| Average True Range (ATR) | 1.76 | 2.63 |
| MACD | 0.36 | -0.11 |
| Stochastic Oscillator | 99.30 | 72.56 |
Price Performance
Historical ComparisonAbout TATT TAT Technologies Ltd.
TAT Technologies Ltd provides solutions and services to the commercial and military aerospace and ground defense industries, focused mainly on three product areas and services: Thermal Management, Power and Actuation, and Maintenance, Repair and Overhaul (MRO). Its product portfolio includes heat exchangers, cooling systems, and mechanical aircraft accessories and systems such as pumps, valves, and turbine power units. Its operating segments are MRO services for aviation components, which derive key revenue, Original equipment manufacturing (OEM) of heat transfer solutions and aviation accessories, MRO services for heat transfer components and OEM of heat transfer solutions, and Overhaul and coating of jet engine components. Geographically, it derives key revenue from the United States.
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.